Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 357,545,100
  • Market Capitalization, $K 357,545
  • Shares Outstanding, K 2,150
  • 60-Month Beta 0.96
  • Price/Earnings ttm 25.50
  • Annual Dividend & Yield 2.05 (1.23%)
  • Most Recent Dividend 0.314 on 06/15/20
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.74 +4.18%
on 09/08/20
168.25 -0.47%
on 09/02/20
+2.64 (+1.60%)
since 08/18/20
3-Month
150.52 +11.26%
on 06/26/20
168.25 -0.47%
on 09/02/20
+15.45 (+10.16%)
since 06/18/20
52-Week
115.53 +44.95%
on 03/23/20
168.25 -0.47%
on 09/02/20
+24.39 (+17.05%)
since 09/18/19

Most Recent Stories

More News
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 63.26 (-0.14%)
AZN : 56.45 (+0.91%)
PFE : 36.63 (-0.52%)
LLY : 154.17 (+1.11%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
ETFs in Focus on Momenta Buyout Deal With JNJ

A number of ETFs could be the best ways for investors to tap the opportunity arising from the Momenta buyout deal.

JNJ : 149.18 (+1.37%)
MNTA : 52.26 (-0.13%)
XLV : 105.54 (-0.15%)
VHT : 203.19 (unch)
IYH : 227.23 (-0.05%)
IHE : 167.46 (+0.78%)
IEIH : 30.57 (+0.43%)
Pharma ETFs Soar on Robust Q2 Earnings

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

JNJ : 149.18 (+1.37%)
PFE : 36.63 (-0.52%)
MRK : 85.81 (+0.20%)
LLY : 154.17 (+1.11%)
BMY : 59.27 (-0.22%)
PPH : 63.26 (-0.14%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
XPH : 45.34 (+0.55%)
FTXH : 24.47 (+0.69%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 63.26 (-0.14%)
LLY : 154.17 (+1.11%)
BMY : 59.27 (-0.22%)
ABBV : 90.11 (+0.54%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 63.26 (-0.14%)
TEVA : 9.48 (+2.05%)
AZN : 56.45 (+0.91%)
ABBV : 90.11 (+0.54%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 63.26 (-0.14%)
AZN : 56.45 (+0.91%)
PFE : 36.63 (-0.52%)
ABBV : 90.11 (+0.54%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 45.34 (+0.55%)
JNJ : 149.18 (+1.37%)
LLY : 154.17 (+1.11%)
CTLT : 84.87 (+0.76%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 63.26 (-0.14%)
JNJ : 149.18 (+1.37%)
PFE : 36.63 (-0.52%)
LLY : 154.17 (+1.11%)
PJP : 65.19 (+0.18%)
IHE : 167.46 (+0.78%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 65.05 (+0.02%)
IBB : 136.32 (+0.51%)
CNCR : 29.08 (+1.59%)
BBH : 157.51 (+0.04%)
FBT : 157.24 (-0.32%)
PTH : 135.31 (+0.56%)
IHF : 202.07 (+0.50%)
IHE : 167.46 (+0.78%)
XPH : 45.34 (+0.55%)
SBIO : 42.53 (+1.00%)
XHS : 75.93 (-0.28%)
PBE : 57.50 (+0.91%)
IDNA : 40.41 (+1.53%)
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus

Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.

JNJ : 149.18 (+1.37%)
XLV : 105.54 (-0.15%)
VHT : 203.19 (unch)
IYH : 227.23 (-0.05%)
IHE : 167.46 (+0.78%)
IEIH : 30.57 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IHE with:

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 168.75
1st Resistance Point 168.11
Last Price 167.46
1st Support Level 166.23
2nd Support Level 164.99

See More

52-Week High 168.25
Last Price 167.46
Fibonacci 61.8% 148.11
Fibonacci 50% 141.89
Fibonacci 38.2% 135.67
52-Week Low 115.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar